Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

About

Member has chosen to not make this information public.

Posts (32)

Tue, Oct 22 6:00am · Meet the Investigator: Donald W. Northfelt, M.D.

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Read about Mayo Clinic Cancer Center.

###

Fri, Sep 27 12:02pm · Read the Latest Research News from Mayo Clinic Cancer Center

Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news.

The September 2019 issue features:

Stay connected to Mayo Clinic Cancer Center

###

Mon, Sep 9 6:00am · Mayo Clinic Cancer Center Renews National Cancer Institute Research Funding

Mayo Clinic Cancer Center has once again successfully renewed its National Cancer Institute (NCI) Cancer Center Support Grant. The grant award provides roughly $28.7 million in funding over five years through 2024, which will mark Mayo Clinic’s 49th year of NCI funding.

Mayo Clinic Cancer Center’s NCI designation as
a comprehensive cancer center was also renewed. To earn the comprehensive
cancer center designation, an institution must demonstrate scientific
leadership, resources, and depth and breadth of research in basic, clinical
and/or population science, as well as substantial transdisciplinary research.

The NCI has recognized Mayo Clinic Cancer Center as the only comprehensive cancer center with three geographic sites in Arizona, Florida and Minnesota. Today the Cancer Center is one of 51 NCI-designated comprehensive cancer centers across the country.

“We’re pleased that the NCI recognized our strong performance over the past five years,” says Robert Diasio, M.D., director of the Mayo Clinic Cancer Center. “These results would not be possible were it not for the efforts of hundreds of clinicians, researchers and support staff who come to work every day looking to improve the lives of patients with cancer.”

The NCI Cancer Center Support Grant has provided more than $146 million to Mayo Clinic Cancer Center over the past 44 years.

Read more about the Mayo Clinic Cancer Center.

###

Wed, Jul 17 6:00am · Read the latest research news from Mayo Clinic Cancer Center

Forefront is the complimentary magazine of the Mayo Clinic Cancer
Center. Published in email and online newsletter editions quarterly, Forefront
highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer
Center news.

The June 2019 issue features:

View the online edition.

View the email newsletter.

Subscribe.

Wed, May 29 6:00am · Celebrate World No Tobacco Day -- Learn About the NCI Cancer Center Cessation Initiative at Mayo Clinic

The World Health Organization recognizes Friday, May, 31, as World No Tobacco Day – the perfect time to celebrate Mayo Clinic’s participation in the National Cancer Institute (NCI) Cancer Center Cessation Initiative

Launched in 2017 as part of the NCI Cancer Moonshot program,
the long-term goal of this initiative is to help cancer centers build and
implement sustainable tobacco cessation treatment programs to routinely address
tobacco cessation with cancer patients.

David Warner, M.D.,
David Warner, M.D.

Mayo Clinic joined this initiative in 2018 when the NCI awarded the Nicotine Dependence Center a supplement to the Mayo Clinic Cancer Center’s NCI Cancer Center Support Grant under the leadership of principal investigator David Warner, M.D. Mayo Clinic is now working with 42 other cancer centers across the nation to:

  • Refine electronic medical records and clinical workflows to ensure the systematic identification and documentation of smokers and the routine delivery of evidence-based tobacco cessation treatment services
  • Overcome patient, clinician, clinic, and health system barriers to providing tobacco cessation treatment services
  • Achieve institutional buy-in that treating tobacco use is a component of organizational “Standard of Care”
  • Create mechanisms to sustain tobacco cessation treatment services so that they continue beyond the funding period of the initiative

Armed with best practices gathered from other cancer centers, the Nicotine Dependence Center is working with care providers across Mayo Clinic to design a system for identifying tobacco users and enrolling them in cessation treatment.

To learn why it’s important for cancer patients to stop using tobacco, watch this Mayo Clinic Minute video:

Tue, Apr 16 6:00am · Meet the Investigator: Yi Lin, M.D. , Ph.D.

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this video, Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.

This article was originally published in the March 2019 edition of Forefront.

SAVOR, SUBSCRIBE, SHARE:  Advancing the Science

  • If you enjoyed this article, you might want to subscribe for regular updates.
  • If you want to share this story with friends, social media links are at the top of the article.
  • And if you want to see other recent stories on the blog, the index page is a great place to start.

Tue, Apr 2 6:00am · Read the Latest Research News from Mayo Clinic Cancer Center

Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news.

The March 2019 issue features:

View the online edition.

View the email newsletter.

Subscribe.

SAVOR, SUBSCRIBE, SHARE:  Advancing the Science

  • If you enjoyed this article, you might want to subscribe for regular updates.
  • If you want to share this story with friends, social media links are at the top of the article.
  • And if you want to see other recent stories on the blog, the index page is a great place to start.

Nov 5, 2018 · Early-phase Cancer Clinical Trials (Phase I) Available at Mayo Clinic

The Early Cancer Therapeutics Group at Mayo Clinic offers patients whose cancers haven’t responded to standard chemotherapy or other treatments the opportunity to join an early-phase clinical trial of a potential new treatment.

Early-phase clinical trials (phase I) determine safe dosage levels and safe methods of treatment delivery. A phase I clinical trial might be the first time a cancer drug or treatment is used in people. These clinical trials offer investigational cancer solutions for cancer therapy resistance — trials for patients whose cancers haven’t responded to standard treatments.

The Early Cancer Therapeutics Group provides access to the most current phase I trials available from Mayo Clinic researchers, pharmaceutical companies and the National Cancer Institute. Phase I clinical trials are available at all three Mayo Clinic campuses in Arizona, Florida and Minnesota.

The Early Cancer Therapeutics Group website provides information for patients interested in participating in Mayo Clinic’s early-phase clinical trials (phase I).

Mayo Clinic has a new website through which patients and referring providers can learn about its early-phase clinical trials for cancer. The website provides an overview of services offered by the Early Cancer Therapeutics Group, including details on who can be seen, what patients can expect from a visit to Mayo Clinic, and a list of current Early Cancer Therapeutics clinical trials.

For more information on trials available through the Early Cancer Therapeutics Group, or to refer a patient, please contact the Mayo Clinic Cancer Center Clinical Trials Referral Office at 855-776-0015 (toll-free).

Learn more about cancer clinical trials at Mayo Clinic.

Contact Us · Privacy Policy